Warby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024. In the quarter to June 2026, revenue grew 9.81%, EPS grew 379.7% and free cash flow fell 71.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow WRBY
Warby Parker Inc. (WRBY) EV/Sales
As of 16 October 2026, Warby Parker Inc. (WRBY) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 1.5× (November 2023) to 6.7× (November 2021); the current reading is higher than 57% of that period. That is in line with the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.7× | (20.64%) |
| FY2024 | 3.4× | 50.77% |
| FY2023 | 2.3× | (4.88%) |
| FY2022 | 2.4× | (57.51%) |
| FY2021 | 5.7× | 2.84% |
| FY2020 | 5.5× | 0.00% |
| FY2019 | 5.5× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.8× | 46.48% |
| Mar 2026 | 2.6× | (5.13%) |
| Dec 2025 | 2.7× | (25.16%) |
| Sep 2025 | 3.7× | 25.09% |
| 21 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| XRAY DENTSPLY SIRONA Inc. compare | 1.0× |
| NVST Envista Holdings Corporation compare | 1.4× |
| ICUI ICU Medical, Inc. compare | 2.3× |
| WRBY Warby Parker Inc. | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.6× |
| STVN Stevanato Group S.p.A. compare | 3.9× |
| ATRC AtriCure, Inc. compare | 4.7× |
| LMAT LeMaitre Vascular, Inc. compare | 6.3× |
| PLSE Pulse Biosciences, Inc compare | 2,555× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)